RCI
PFE icon

RS Crum Inc’s Pfizer PFE Stock Holding History

RS Crum Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
+7,679
New +$204K 0.04% 97
2025
Q1 		– Sell
-7,679
Closed -$204K – 90
2024
Q4 		$204K Sell
7,679
-194
-2% -$5.26K 0.05% 87
2024
Q3 		$228K Buy
7,873
+69
+0.9% +$2.01K 0.05% 87
2024
Q2 		$218K Hold
7,804
– – 0.06% 88
2024
Q1 		$217K Hold
7,804
– – 0.06% 78
2023
Q4 		$225K Hold
7,804
– – 0.07% 76
2023
Q3 		$259K Buy
+7,804
New +$276K 0.09% 69

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

RS Crum Inc's PFE Position: Q1 2026 in Review

RS Crum Inc opened a new position in Pfizer (PFE) in Q1 2026: 7,679 shares worth $216K. The stake represents 0.04% of the portfolio and ranks #97 among its holdings. This is a return to the name: RS Crum Inc previously reported a position in PFE as recently as Q4 2024.

RS Crum Inc first reported a position in PFE in Q3 2023 and has held it in 7 quarters since. The position peaked at $259K in Q3 2023. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • RS Crum Inc held 7,679 shares of Pfizer worth $216K as of Q1 2026.
  • Pfizer was a new RS Crum Inc position in Q1 2026.
  • Pfizer made up 0.04% of RS Crum Inc's portfolio in Q1 2026, its #97 holding.
  • RS Crum Inc first reported a position in Pfizer in Q3 2023 and has held it in 7 quarters since.
  • RS Crum Inc's Pfizer position peaked at $259K in Q3 2023.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on RS Crum Inc's 13F filing for Q1 2026, filed 15 Apr 2026.